Trial intelligence / Profile preview

Amorolfine vs Nd:YAG vs Combination for Non-dermatophyte Onychomycosis

NCT02812043Phase 4Completed

Sponsor
Mahidol University
Start
Aug 2016
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amorolfine in onychomycosis, sponsored by Mahidol University. Started Aug 2016; status: completed.

02

Drugs

amorolfine
03

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT02812043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02812043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call